CAMBRIDGE, Mass., Sept. 23, 2015 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc.(NASDAQ:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases, announced today that the company will participate in the 2015 Leerink Rare Disease Roundtable in New York City. Gregory Perry, Chief Financial Officer of Aegerion, is scheduled to present in a fireside chat on Wednesday, September 30, 2015 at 10:15 a.m. ET.
The presentation will be webcast live and may be accessed for up to 30 days following the conference by visiting the “Investors” section of Aegerion’s website, www.aegerion.com.
About Aegerion Pharmaceuticals
Aegerion Pharmaceuticals is a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases. For more information about the company, please visit www.aegerion.com.
CONTACT: Aegerion Pharmaceuticals, Inc. Amanda Murphy Associate Director, Investor Relations 857-242-5024
Help employers find you! Check out all the jobs and post your resume.
